Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiologic, Histologic and Immunologic Response to Radioembolization of Hepatic Tumors

NCT01775280 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT01775280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01775280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiologic, Histologic and Immunologic Response to Radioembolization of Hepatic Tumors
Lead sponsor
University of Zurich
Phase
Phase 2
Overall status
Withdrawn
Start date
October 31, 2012
Completion date
October 31, 2015
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, intrahepatic cholangiocarcinoma, liver metastasis